Women's imaging issues seem to be featured everywhere. The momentum has been building over the past decade, propelled by the evident importance of screening mammography, the integration of multimodalities into breast imaging, the success of fibroid embolization, and the emergence of certain distinctions between male and female pathology in lung and cardiac disease.
Women's imaging issues seem to be featured everywhere. The momentum has been building over the past decade, propelled by the evident importance of screening mammography, the integration of multimodalities into breast imaging, the success of fibroid embolization, and the emergence of certain distinctions between male and female pathology in lung and cardiac disease.
Most practices, large and small, have areas dedicated to women's imaging. Many journals and Internet sites have a women's health section or concentration. For years, Diagnostic Imaging has featured special sections and supplements devoted to women's imaging.
There is even a buzz within radiology to recognize women's imaging as its own subspecialty. There are about 30 fellowships for women's imaging, and they've done well in the last several years, according to Dr. Ellen Mendelson, medical director of breast imaging at Northwestern Memorial Hospital in Chicago. But radiology residency programs could do a better job with women's imaging.
"Residencies have to put all the women's imaging curricula into an easy-to-get format, including musculoskeletal for osteoporosis," Mendelson said.
Beyond academia, women's imaging has already been stamped a subspecialty. Women's imaging centers appear everywhere. In these places, patients can have their annual mammogram, a bone mineral test, and gynecological ultrasonography. In our special Women's Health section, we feature one center's journey through renovation and expansion (see page 49). As this is the wave of the future, it wouldn't hurt to learn some tricks from someone else's trials and tribulations.
Mr. Kaiser is news editor of Diagnostic Imaging.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.